Yang Qian-Hui, Zhang Yan, Zhang Xiao-Min, Li Xiao-Rong
Tianjin Medical University Eye Hospital, Tianjin Medical University Eye Institute & Tianjin Medical University School of Optometry and Ophthalmology, Tianjin 300384, China.
Int J Ophthalmol. 2019 Feb 18;12(2):302-311. doi: 10.18240/ijo.2019.02.19. eCollection 2019.
To investigate the pooled prevalence of diabetic retinopathy (DR), proliferative DR (PDR) and nonproliferative DR (NPDR) in Asian type 2 diabetes mellitus (T2DM) patients.
We performed a systematic search online search using PubMed, EMBASE, Web of Science, the Cochrane Library, and China WeiPu Library to identify eligible studies that reported the prevalence of DR, PDR and NPDR in Asian T2DM patients. Effect size (ES) with 95% confidence interval (CI) was used to evaluate the prevalence of DR, PDR and NPDR in Asian T2DM patients, respectively.
There were 41 references and 48 995 T2DM patients involved in this study. The prevalence of DR, PDR, and NPDR was 28%, 6%, and 27% in T2DM patients, respectively; while the prevalence of PDR and NPDR in DR patients was 17% and 83%, respectively. Subgroup analysis showed that prevalence of DR in T2DM patients from Singaporean, Indian, South Korean, Malaysian, Asian, and Chinese was 33%, 42%, 16%, 35%, 21% and 25%, respectively. In T2DM patients with NPDR from Indian, South Korean, Malaysian, Asian, Chinese, higher prevalence was found than that in PDR patients (45% 17%, 13% 3%, 30% 5%, 23% 2% and 22% 3%), as well as in DR patients (74% 26%, 81% 19%, 86% 14%, 92% 8% and 85% 15%). The prevalence of PDR in T2DM from India was higher than patients from other locations of Asia, and the same results were also observed in NPDR patients.
In either T2DM Asian patients or DR patients, NPDR is more common than PDR. Based on our results, we should pay more attention to NPDR screening and management in T2DM patients, and we also recommend suitable interventions to prevent its progression.
调查亚洲2型糖尿病(T2DM)患者中糖尿病视网膜病变(DR)、增殖性DR(PDR)和非增殖性DR(NPDR)的合并患病率。
我们使用PubMed、EMBASE、科学网、Cochrane图书馆和中国维普图书馆进行了系统的在线搜索,以确定报告亚洲T2DM患者中DR、PDR和NPDR患病率的合格研究。分别使用效应量(ES)及其95%置信区间(CI)来评估亚洲T2DM患者中DR、PDR和NPDR的患病率。
本研究纳入41篇参考文献和48995例T2DM患者。T2DM患者中DR、PDR和NPDR的患病率分别为28%、6%和27%;而DR患者中PDR和NPDR的患病率分别为17%和83%。亚组分析显示,新加坡、印度、韩国、马来西亚、亚洲及中国的T2DM患者中DR的患病率分别为33%、42%、16%、35%、21%和25%。在印度、韩国、马来西亚、亚洲及中国的NPDR的T2DM患者中,其患病率高于PDR患者(分别为45%对17%、13%对3%、30%对5%、23%对2%和22%对3%),也高于DR患者(分别为74%对26%、81%对19%、86%对14%、92%对8%和85%对15%)。印度T2DM患者中PDR的患病率高于亚洲其他地区的患者,NPDR患者也观察到同样的结果。
在亚洲T2DM患者或DR患者中,NPDR比PDR更常见。基于我们的研究结果,我们应更加关注T2DM患者中NPDR的筛查和管理,并且我们还建议采取适当的干预措施以防止其进展。